Global Expertise

The discovery and development of important healthcare technologies are not confined to geographic borders. There are important technology based companies now being developed in Asiana and Europe which will need to find strategic partners in America to maximize the commercial opportunities for their products/services.

In turn, a majority of American medical device and biotechnology companies conduct clinical trials outside of the United States and will ultimately need to partner to find distribution expertise in local markets around the world.

Crawford Capital has positioned itself as a global leader in healthcare technology venture investment. With offices in New Jersey and California serving the major US markets for healthcare technology, we also maintain offices in Australia and Europe. We are able to provide our portfolio companies with access to our global expertise and network of investors, business associations and contacts – which is often invaluable in facilitating strategic alliances, effective international clinical trials and advanced funding.

We are members of the National Venture Capital Association in America, the Australian Venture Capital Association Limited, and the European Venture Capital Association. Our global contacts, relationships and local knowledge of the markets and regulatory environments, developed first-hand in managing successful business on five continents, are unsurpassed.

We welcome the opportunity to evaluate companies in Europe and Asiana for potential investment. Please direct all initial inquiries to decisions@crawfordcapital.com. We will respond to you from the respective office best suited to evaluate the opportunity.